{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:58:17Z","timestamp":1760785097988,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR001414"],"award-info":[{"award-number":["UL1 TR001414"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005277","name":"Presbyterian Historical Society","doi-asserted-by":"publisher","award":["KL2TR001416","R01AR078340","R01NS120060","R21NS114918","U24NS107210","UL1TR001414"],"award-info":[{"award-number":["KL2TR001416","R01AR078340","R01NS120060","R21NS114918","U24NS107210","UL1TR001414"]}],"id":[{"id":"10.13039\/100005277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.nmd.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T23:23:00Z","timestamp":1661296980000},"page":"800-805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlations of disease severity outcome measures in inclusion body myositis"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1713-545X","authenticated-orcid":false,"given":"Namita A.","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Cauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Wencel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Irani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton M.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Armando","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahseen","family":"Mozaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2022.08.005_bib0001","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/CON.0000000000000790","article-title":"Sporadic inclusion body myositis and other rimmed vacuolar myopathies","volume":"25","author":"Weihl","year":"2019","journal-title":"Continuum"},{"key":"10.1016\/j.nmd.2022.08.005_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nan.12384","article-title":"Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy","volume":"43","author":"Weihl","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2022.08.005_bib0003","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nmd.2022.08.005_bib0004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/BOR.0000000000000436","article-title":"Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment","volume":"29","author":"Schmidt","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.nmd.2022.08.005_bib0005","first-page":"5L","article-title":"Rapamycin vs. placebo for the treatment of inclusion body myositis: improvement of the 6 min walking distance, a functional scale, the FVC and muscle quantitative MRI [abstract]","volume":"69","author":"Benveniste","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.nmd.2022.08.005_bib0006","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/mus.20958","article-title":"Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity","volume":"37","author":"Jackson","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.08.005_bib0007","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.nmd.2012.05.004","article-title":"Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis","volume":"22","author":"Allenbach","year":"2012","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2022.08.005_bib0008","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nmd.2013.02.010","article-title":"Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials","volume":"23","author":"Cortese","year":"2013","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2022.08.005_bib0009","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.nmd.2014.04.009","article-title":"Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials","volume":"24","author":"Hogrel","year":"2014","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.nmd.2022.08.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-325141","article-title":"Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis","author":"Sangha","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"10.1016\/j.nmd.2022.08.005_bib0011","doi-asserted-by":"crossref","first-page":"e1374","DOI":"10.1212\/WNL.0000000000200013","article-title":"Immunophenotyping of inclusion body myositis blood T and NK cells","volume":"98","author":"Goyal","year":"2022","journal-title":"Neurology"},{"year":"1993","author":"Kendall","series-title":"Muscles: Testing and Function","key":"10.1016\/j.nmd.2022.08.005_bib0012"},{"key":"10.1016\/j.nmd.2022.08.005_bib0013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mus.21880","article-title":"The Oculobulbar Facial Respiratory score is a tool to assess bulbar function in myasthenia gravis patients","volume":"43","author":"Farrugia","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.08.005_bib0014","first-page":"614","article-title":"Biostatistics 104: correlational analysis","volume":"44","author":"Chan","year":"2003","journal-title":"Singapore Med J"},{"key":"10.1016\/j.nmd.2022.08.005_bib0015","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(19)30200-5","article-title":"Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Hanna","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2022.08.005_bib0016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(15)00242-2","article-title":"MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study","volume":"15","author":"Morrow","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2022.08.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2021-326460","article-title":"Still seeking the holy grail of outcome measures in inclusion body myositis","author":"Hogrel","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2022.08.005_bib0018","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.26859","article-title":"Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups","volume":"62","author":"Oldroyd","year":"2020","journal-title":"Muscle Nerve"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:45Z","timestamp":1760775165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622006344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0960896622006344"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.08.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlations of disease severity outcome measures in inclusion body myositis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}